NVST
Envista Holdings Corp
NYSE: NVST · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$25.90
-2.23% today
Updated 2026-04-29
Market cap
$4.22B
P/E ratio
92.50
P/S ratio
1.55x
EPS (TTM)
$0.28
Dividend yield
—
52W range
$16 – $30
Volume
2.4M
Envista Holdings Corp (NVST) Financial statements
SEC filings — annual and quarterly data.
Profit margin
1.73%
Operating margin
10.70%
ROE
1.56%
ROA
2.78%
Debt/equity
0.55x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2015 | $2.74B | $275.50M | 55.62% | 12.79% | 10.07% |
| 2016 | $2.79B | $272.00M | 57.92% | 14.46% | 9.77% |
| 2017 | $2.81B | $301.10M | 57.90% | 13.75% | 10.71% |
| 2018 | $2.84B | $230.70M | 56.59% | 10.49% | 8.11% |
| 2019 | $2.28B | $217.60M | 59.16% | 10.32% | 9.52% |
| 2020 | $1.93B | $33.30M | 55.63% | 2.25% | 1.73% |
| 2021 | $2.51B | $340.50M | 58.29% | 12.20% | 13.57% |
| 2022 | $2.57B | $243.10M | 57.93% | 12.42% | 9.46% |
| 2023 | $2.57B | $-100.20M | 56.13% | 1.23% | -3.90% |
| 2024 | $2.51B | $-1.12B | 55.43% | -41.35% | -44.56% |
| 2025 | $2.72B | $47.00M | 55.02% | 8.30% | 1.73% |